메뉴 건너뛰기




Volumn 75, Issue 3, 2001, Pages 1547-1550

DNA vaccination with the human immunodeficiency virus type 1 SF162ΔV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8+ T-cell-depleted rhesus macaques

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE SF162 DELTA V2; VIRUS VACCINE SHIV162 P4;

EID: 0035148591     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.3.1547-1550.2001     Document Type: Article
Times cited : (89)

References (22)
  • 19
    • 0031666180 scopus 로고    scopus 로고
    • An envelope modification that renders a primary, neutralization-resistant, clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades
    • (1998) J. Virol. , vol.72 , pp. 7840-7845
    • Stamatatos, L.1    Cheng-Maver, C.2
  • 20
    • 0029095364 scopus 로고
    • Structural modulations of the envelope gp120 glycoprotein of human unmunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding
    • (1995) J. Virol. , vol.69 , pp. 6191-6198
    • Stamatatos, L.1    Cheng-Mayer, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.